Presents Positive Preclinical Safety and Efficacy Data for its Novel Investigational Cancer Treatment TXR-311 - Timot...

Cancer Photo

Cancer
3 years 297 Views
Category:
Description:
Timothy Heuer, Ph.D., twoXAR Pharmaceuticals discusses Presents Positive Preclinical Safety & Efficacy Data for its Novel Investigational Cancer Treatment TXR-311

AACR2020
https://www.prnewswire.com/news-releases/twoxar-pharmaceuticals-presents-positive-preclinical-safety-and-efficacy-data-for-its-novel-investigational-cancer-treatment-txr-311-301080554.html